Symbol="KZIA"
AssetType="Common Stock"
Name="Kazia Therapeutics Ltd ADR"
Description="Kazia Therapeutics Limited, a biotechnology company focused on oncology, develops anticancer drugs. The company is headquartered in Sydney, Australia."
CIK="1075880"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="THREE INTERNATIONAL TOWERS LEVEL 24,, 300 BARANGAROO AVENUE, SYDNEY NSW, AUSTRALIA"
FiscalYearEnd="June"
LatestQuarter="2022-09-30"
MarketCapitalization="23496600"
EBITDA="-23103516"
PERatio="None"
PEGRatio="None"
BookValue="0.71"
DividendPerShare="0"
DividendYield="0"
EPS="-1.17"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.432"
ReturnOnEquityTTM="-1.35"
RevenueTTM="0"
GrossProfitTTM="10000"
DilutedEPSTTM="-1.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.997"
AnalystTargetPrice="1.98"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="897.79"
PriceToBookRatio="0.688"
EVToRevenue="0.943"
EVToEBITDA="-0.179"
Beta="2.104"
num_52WeekHigh="1.73"
num_52WeekLow="0.5"
num_50DayMovingAverage="1.056"
num_200DayMovingAverage="0.984"
SharesOutstanding="23634900"
DividendDate="2017-07-14"
ExDividendDate="None"
symbol="KZIA"
open="0.90"
high="0.96"
low="0.86"
price="0.90"
volume="7723.00"
latest_trading_day="2023-08-22"
previous_close="0.91"
change="-0.01"
change_percent="-1.1098%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="34"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="136225"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.09"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="155"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0021.jpeg"
image_negative_thumbnail_id_2="1120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_neutral_thumbnail_id_1="564"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="678"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0030.jpeg"
image_positive_thumbnail_id_2="986"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0148.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
